Global Cachexia Treatment Market 2023 by Company, Regions, Type and Application, Forecast to 2029
Cachexia is a wasting syndrome characterized by extreme weight loss, anorexia, asthenia and anaemia. This syndrome affects populations who were in the late stages of severe diseases like cancer, HIV or AIDS, kidney disease, COPD and congestive heart failure (CHF). Appetite stimulants, anti-inflammatory drugs, Corticosteroids, Enobosarm and Other Anabolics are most commonly used for cachexia treatment.
According to our (Global Info Research) latest study, the global Cachexia Treatment market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Cachexia Treatment market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Cachexia Treatment market size and forecasts, in consumption value ($ Million), 2018-2029
Global Cachexia Treatment market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Cachexia Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Cachexia Treatment market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cachexia Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cachexia Treatment market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Alder Biopharmaceuticals Inc., GTx Inc., Helsinn Group, Merck & Co. Inc. and Bristol-Myers Squibb Company, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Cachexia Treatment market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Cachexia Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cachexia Treatment, with revenue, gross margin and global market share of Cachexia Treatment from 2018 to 2023.
Chapter 3, the Cachexia Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Cachexia Treatment market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Cachexia Treatment.
Chapter 13, to describe Cachexia Treatment research findings and conclusion.
According to our (Global Info Research) latest study, the global Cachexia Treatment market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Cachexia Treatment market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Cachexia Treatment market size and forecasts, in consumption value ($ Million), 2018-2029
Global Cachexia Treatment market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Cachexia Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Cachexia Treatment market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cachexia Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cachexia Treatment market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Alder Biopharmaceuticals Inc., GTx Inc., Helsinn Group, Merck & Co. Inc. and Bristol-Myers Squibb Company, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Cachexia Treatment market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Weight Loss Stabilizers
- Appetite Stimulants
- Progestogens
- Corticosteroids
- Combination therapies
- Others
- Hospital Pharmacies
- Retail Pharmacies
- Drug Stores
- Online
- Alder Biopharmaceuticals Inc.
- GTx Inc.
- Helsinn Group
- Merck & Co. Inc.
- Bristol-Myers Squibb Company
- Helsinn Healthcare S.A.
- PsiOxus
- Purdue Pharma L.P.
- Eterna Zentaris Inc.
- Aphios Corporation
- Neurim
- Novartis AG
- SkyePharma
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Cachexia Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cachexia Treatment, with revenue, gross margin and global market share of Cachexia Treatment from 2018 to 2023.
Chapter 3, the Cachexia Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Cachexia Treatment market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Cachexia Treatment.
Chapter 13, to describe Cachexia Treatment research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Cachexia Treatment
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Cachexia Treatment by Type
1.3.1 Overview: Global Cachexia Treatment Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Cachexia Treatment Consumption Value Market Share by Type in 2022
1.3.3 Weight Loss Stabilizers
1.3.4 Appetite Stimulants
1.3.5 Progestogens
1.3.6 Corticosteroids
1.3.7 Combination therapies
1.3.8 Others
1.4 Global Cachexia Treatment Market by Application
1.4.1 Overview: Global Cachexia Treatment Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital Pharmacies
1.4.3 Retail Pharmacies
1.4.4 Drug Stores
1.4.5 Online
1.5 Global Cachexia Treatment Market Size & Forecast
1.6 Global Cachexia Treatment Market Size and Forecast by Region
1.6.1 Global Cachexia Treatment Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Cachexia Treatment Market Size by Region, (2018-2029)
1.6.3 North America Cachexia Treatment Market Size and Prospect (2018-2029)
1.6.4 Europe Cachexia Treatment Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Cachexia Treatment Market Size and Prospect (2018-2029)
1.6.6 South America Cachexia Treatment Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Cachexia Treatment Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Alder Biopharmaceuticals Inc.
2.1.1 Alder Biopharmaceuticals Inc. Details
2.1.2 Alder Biopharmaceuticals Inc. Major Business
2.1.3 Alder Biopharmaceuticals Inc. Cachexia Treatment Product and Solutions
2.1.4 Alder Biopharmaceuticals Inc. Cachexia Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Alder Biopharmaceuticals Inc. Recent Developments and Future Plans
2.2 GTx Inc.
2.2.1 GTx Inc. Details
2.2.2 GTx Inc. Major Business
2.2.3 GTx Inc. Cachexia Treatment Product and Solutions
2.2.4 GTx Inc. Cachexia Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 GTx Inc. Recent Developments and Future Plans
2.3 Helsinn Group
2.3.1 Helsinn Group Details
2.3.2 Helsinn Group Major Business
2.3.3 Helsinn Group Cachexia Treatment Product and Solutions
2.3.4 Helsinn Group Cachexia Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Helsinn Group Recent Developments and Future Plans
2.4 Merck & Co. Inc.
2.4.1 Merck & Co. Inc. Details
2.4.2 Merck & Co. Inc. Major Business
2.4.3 Merck & Co. Inc. Cachexia Treatment Product and Solutions
2.4.4 Merck & Co. Inc. Cachexia Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Merck & Co. Inc. Recent Developments and Future Plans
2.5 Bristol-Myers Squibb Company
2.5.1 Bristol-Myers Squibb Company Details
2.5.2 Bristol-Myers Squibb Company Major Business
2.5.3 Bristol-Myers Squibb Company Cachexia Treatment Product and Solutions
2.5.4 Bristol-Myers Squibb Company Cachexia Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Bristol-Myers Squibb Company Recent Developments and Future Plans
2.6 Helsinn Healthcare S.A.
2.6.1 Helsinn Healthcare S.A. Details
2.6.2 Helsinn Healthcare S.A. Major Business
2.6.3 Helsinn Healthcare S.A. Cachexia Treatment Product and Solutions
2.6.4 Helsinn Healthcare S.A. Cachexia Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Helsinn Healthcare S.A. Recent Developments and Future Plans
2.7 PsiOxus
2.7.1 PsiOxus Details
2.7.2 PsiOxus Major Business
2.7.3 PsiOxus Cachexia Treatment Product and Solutions
2.7.4 PsiOxus Cachexia Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 PsiOxus Recent Developments and Future Plans
2.8 Purdue Pharma L.P.
2.8.1 Purdue Pharma L.P. Details
2.8.2 Purdue Pharma L.P. Major Business
2.8.3 Purdue Pharma L.P. Cachexia Treatment Product and Solutions
2.8.4 Purdue Pharma L.P. Cachexia Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Purdue Pharma L.P. Recent Developments and Future Plans
2.9 Eterna Zentaris Inc.
2.9.1 Eterna Zentaris Inc. Details
2.9.2 Eterna Zentaris Inc. Major Business
2.9.3 Eterna Zentaris Inc. Cachexia Treatment Product and Solutions
2.9.4 Eterna Zentaris Inc. Cachexia Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Eterna Zentaris Inc. Recent Developments and Future Plans
2.10 Aphios Corporation
2.10.1 Aphios Corporation Details
2.10.2 Aphios Corporation Major Business
2.10.3 Aphios Corporation Cachexia Treatment Product and Solutions
2.10.4 Aphios Corporation Cachexia Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Aphios Corporation Recent Developments and Future Plans
2.11 Neurim
2.11.1 Neurim Details
2.11.2 Neurim Major Business
2.11.3 Neurim Cachexia Treatment Product and Solutions
2.11.4 Neurim Cachexia Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Neurim Recent Developments and Future Plans
2.12 Novartis AG
2.12.1 Novartis AG Details
2.12.2 Novartis AG Major Business
2.12.3 Novartis AG Cachexia Treatment Product and Solutions
2.12.4 Novartis AG Cachexia Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Novartis AG Recent Developments and Future Plans
2.13 SkyePharma
2.13.1 SkyePharma Details
2.13.2 SkyePharma Major Business
2.13.3 SkyePharma Cachexia Treatment Product and Solutions
2.13.4 SkyePharma Cachexia Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 SkyePharma Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Cachexia Treatment Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Cachexia Treatment by Company Revenue
3.2.2 Top 3 Cachexia Treatment Players Market Share in 2022
3.2.3 Top 6 Cachexia Treatment Players Market Share in 2022
3.3 Cachexia Treatment Market: Overall Company Footprint Analysis
3.3.1 Cachexia Treatment Market: Region Footprint
3.3.2 Cachexia Treatment Market: Company Product Type Footprint
3.3.3 Cachexia Treatment Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Cachexia Treatment Consumption Value and Market Share by Type (2018-2023)
4.2 Global Cachexia Treatment Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Cachexia Treatment Consumption Value Market Share by Application (2018-2023)
5.2 Global Cachexia Treatment Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Cachexia Treatment Consumption Value by Type (2018-2029)
6.2 North America Cachexia Treatment Consumption Value by Application (2018-2029)
6.3 North America Cachexia Treatment Market Size by Country
6.3.1 North America Cachexia Treatment Consumption Value by Country (2018-2029)
6.3.2 United States Cachexia Treatment Market Size and Forecast (2018-2029)
6.3.3 Canada Cachexia Treatment Market Size and Forecast (2018-2029)
6.3.4 Mexico Cachexia Treatment Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Cachexia Treatment Consumption Value by Type (2018-2029)
7.2 Europe Cachexia Treatment Consumption Value by Application (2018-2029)
7.3 Europe Cachexia Treatment Market Size by Country
7.3.1 Europe Cachexia Treatment Consumption Value by Country (2018-2029)
7.3.2 Germany Cachexia Treatment Market Size and Forecast (2018-2029)
7.3.3 France Cachexia Treatment Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Cachexia Treatment Market Size and Forecast (2018-2029)
7.3.5 Russia Cachexia Treatment Market Size and Forecast (2018-2029)
7.3.6 Italy Cachexia Treatment Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Cachexia Treatment Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Cachexia Treatment Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Cachexia Treatment Market Size by Region
8.3.1 Asia-Pacific Cachexia Treatment Consumption Value by Region (2018-2029)
8.3.2 China Cachexia Treatment Market Size and Forecast (2018-2029)
8.3.3 Japan Cachexia Treatment Market Size and Forecast (2018-2029)
8.3.4 South Korea Cachexia Treatment Market Size and Forecast (2018-2029)
8.3.5 India Cachexia Treatment Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Cachexia Treatment Market Size and Forecast (2018-2029)
8.3.7 Australia Cachexia Treatment Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Cachexia Treatment Consumption Value by Type (2018-2029)
9.2 South America Cachexia Treatment Consumption Value by Application (2018-2029)
9.3 South America Cachexia Treatment Market Size by Country
9.3.1 South America Cachexia Treatment Consumption Value by Country (2018-2029)
9.3.2 Brazil Cachexia Treatment Market Size and Forecast (2018-2029)
9.3.3 Argentina Cachexia Treatment Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Cachexia Treatment Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Cachexia Treatment Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Cachexia Treatment Market Size by Country
10.3.1 Middle East & Africa Cachexia Treatment Consumption Value by Country (2018-2029)
10.3.2 Turkey Cachexia Treatment Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Cachexia Treatment Market Size and Forecast (2018-2029)
10.3.4 UAE Cachexia Treatment Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Cachexia Treatment Market Drivers
11.2 Cachexia Treatment Market Restraints
11.3 Cachexia Treatment Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Cachexia Treatment Industry Chain
12.2 Cachexia Treatment Upstream Analysis
12.3 Cachexia Treatment Midstream Analysis
12.4 Cachexia Treatment Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Cachexia Treatment
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Cachexia Treatment by Type
1.3.1 Overview: Global Cachexia Treatment Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Cachexia Treatment Consumption Value Market Share by Type in 2022
1.3.3 Weight Loss Stabilizers
1.3.4 Appetite Stimulants
1.3.5 Progestogens
1.3.6 Corticosteroids
1.3.7 Combination therapies
1.3.8 Others
1.4 Global Cachexia Treatment Market by Application
1.4.1 Overview: Global Cachexia Treatment Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital Pharmacies
1.4.3 Retail Pharmacies
1.4.4 Drug Stores
1.4.5 Online
1.5 Global Cachexia Treatment Market Size & Forecast
1.6 Global Cachexia Treatment Market Size and Forecast by Region
1.6.1 Global Cachexia Treatment Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Cachexia Treatment Market Size by Region, (2018-2029)
1.6.3 North America Cachexia Treatment Market Size and Prospect (2018-2029)
1.6.4 Europe Cachexia Treatment Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Cachexia Treatment Market Size and Prospect (2018-2029)
1.6.6 South America Cachexia Treatment Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Cachexia Treatment Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Alder Biopharmaceuticals Inc.
2.1.1 Alder Biopharmaceuticals Inc. Details
2.1.2 Alder Biopharmaceuticals Inc. Major Business
2.1.3 Alder Biopharmaceuticals Inc. Cachexia Treatment Product and Solutions
2.1.4 Alder Biopharmaceuticals Inc. Cachexia Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Alder Biopharmaceuticals Inc. Recent Developments and Future Plans
2.2 GTx Inc.
2.2.1 GTx Inc. Details
2.2.2 GTx Inc. Major Business
2.2.3 GTx Inc. Cachexia Treatment Product and Solutions
2.2.4 GTx Inc. Cachexia Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 GTx Inc. Recent Developments and Future Plans
2.3 Helsinn Group
2.3.1 Helsinn Group Details
2.3.2 Helsinn Group Major Business
2.3.3 Helsinn Group Cachexia Treatment Product and Solutions
2.3.4 Helsinn Group Cachexia Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Helsinn Group Recent Developments and Future Plans
2.4 Merck & Co. Inc.
2.4.1 Merck & Co. Inc. Details
2.4.2 Merck & Co. Inc. Major Business
2.4.3 Merck & Co. Inc. Cachexia Treatment Product and Solutions
2.4.4 Merck & Co. Inc. Cachexia Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Merck & Co. Inc. Recent Developments and Future Plans
2.5 Bristol-Myers Squibb Company
2.5.1 Bristol-Myers Squibb Company Details
2.5.2 Bristol-Myers Squibb Company Major Business
2.5.3 Bristol-Myers Squibb Company Cachexia Treatment Product and Solutions
2.5.4 Bristol-Myers Squibb Company Cachexia Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Bristol-Myers Squibb Company Recent Developments and Future Plans
2.6 Helsinn Healthcare S.A.
2.6.1 Helsinn Healthcare S.A. Details
2.6.2 Helsinn Healthcare S.A. Major Business
2.6.3 Helsinn Healthcare S.A. Cachexia Treatment Product and Solutions
2.6.4 Helsinn Healthcare S.A. Cachexia Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Helsinn Healthcare S.A. Recent Developments and Future Plans
2.7 PsiOxus
2.7.1 PsiOxus Details
2.7.2 PsiOxus Major Business
2.7.3 PsiOxus Cachexia Treatment Product and Solutions
2.7.4 PsiOxus Cachexia Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 PsiOxus Recent Developments and Future Plans
2.8 Purdue Pharma L.P.
2.8.1 Purdue Pharma L.P. Details
2.8.2 Purdue Pharma L.P. Major Business
2.8.3 Purdue Pharma L.P. Cachexia Treatment Product and Solutions
2.8.4 Purdue Pharma L.P. Cachexia Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Purdue Pharma L.P. Recent Developments and Future Plans
2.9 Eterna Zentaris Inc.
2.9.1 Eterna Zentaris Inc. Details
2.9.2 Eterna Zentaris Inc. Major Business
2.9.3 Eterna Zentaris Inc. Cachexia Treatment Product and Solutions
2.9.4 Eterna Zentaris Inc. Cachexia Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Eterna Zentaris Inc. Recent Developments and Future Plans
2.10 Aphios Corporation
2.10.1 Aphios Corporation Details
2.10.2 Aphios Corporation Major Business
2.10.3 Aphios Corporation Cachexia Treatment Product and Solutions
2.10.4 Aphios Corporation Cachexia Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Aphios Corporation Recent Developments and Future Plans
2.11 Neurim
2.11.1 Neurim Details
2.11.2 Neurim Major Business
2.11.3 Neurim Cachexia Treatment Product and Solutions
2.11.4 Neurim Cachexia Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Neurim Recent Developments and Future Plans
2.12 Novartis AG
2.12.1 Novartis AG Details
2.12.2 Novartis AG Major Business
2.12.3 Novartis AG Cachexia Treatment Product and Solutions
2.12.4 Novartis AG Cachexia Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Novartis AG Recent Developments and Future Plans
2.13 SkyePharma
2.13.1 SkyePharma Details
2.13.2 SkyePharma Major Business
2.13.3 SkyePharma Cachexia Treatment Product and Solutions
2.13.4 SkyePharma Cachexia Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 SkyePharma Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Cachexia Treatment Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Cachexia Treatment by Company Revenue
3.2.2 Top 3 Cachexia Treatment Players Market Share in 2022
3.2.3 Top 6 Cachexia Treatment Players Market Share in 2022
3.3 Cachexia Treatment Market: Overall Company Footprint Analysis
3.3.1 Cachexia Treatment Market: Region Footprint
3.3.2 Cachexia Treatment Market: Company Product Type Footprint
3.3.3 Cachexia Treatment Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Cachexia Treatment Consumption Value and Market Share by Type (2018-2023)
4.2 Global Cachexia Treatment Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Cachexia Treatment Consumption Value Market Share by Application (2018-2023)
5.2 Global Cachexia Treatment Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Cachexia Treatment Consumption Value by Type (2018-2029)
6.2 North America Cachexia Treatment Consumption Value by Application (2018-2029)
6.3 North America Cachexia Treatment Market Size by Country
6.3.1 North America Cachexia Treatment Consumption Value by Country (2018-2029)
6.3.2 United States Cachexia Treatment Market Size and Forecast (2018-2029)
6.3.3 Canada Cachexia Treatment Market Size and Forecast (2018-2029)
6.3.4 Mexico Cachexia Treatment Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Cachexia Treatment Consumption Value by Type (2018-2029)
7.2 Europe Cachexia Treatment Consumption Value by Application (2018-2029)
7.3 Europe Cachexia Treatment Market Size by Country
7.3.1 Europe Cachexia Treatment Consumption Value by Country (2018-2029)
7.3.2 Germany Cachexia Treatment Market Size and Forecast (2018-2029)
7.3.3 France Cachexia Treatment Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Cachexia Treatment Market Size and Forecast (2018-2029)
7.3.5 Russia Cachexia Treatment Market Size and Forecast (2018-2029)
7.3.6 Italy Cachexia Treatment Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Cachexia Treatment Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Cachexia Treatment Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Cachexia Treatment Market Size by Region
8.3.1 Asia-Pacific Cachexia Treatment Consumption Value by Region (2018-2029)
8.3.2 China Cachexia Treatment Market Size and Forecast (2018-2029)
8.3.3 Japan Cachexia Treatment Market Size and Forecast (2018-2029)
8.3.4 South Korea Cachexia Treatment Market Size and Forecast (2018-2029)
8.3.5 India Cachexia Treatment Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Cachexia Treatment Market Size and Forecast (2018-2029)
8.3.7 Australia Cachexia Treatment Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Cachexia Treatment Consumption Value by Type (2018-2029)
9.2 South America Cachexia Treatment Consumption Value by Application (2018-2029)
9.3 South America Cachexia Treatment Market Size by Country
9.3.1 South America Cachexia Treatment Consumption Value by Country (2018-2029)
9.3.2 Brazil Cachexia Treatment Market Size and Forecast (2018-2029)
9.3.3 Argentina Cachexia Treatment Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Cachexia Treatment Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Cachexia Treatment Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Cachexia Treatment Market Size by Country
10.3.1 Middle East & Africa Cachexia Treatment Consumption Value by Country (2018-2029)
10.3.2 Turkey Cachexia Treatment Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Cachexia Treatment Market Size and Forecast (2018-2029)
10.3.4 UAE Cachexia Treatment Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Cachexia Treatment Market Drivers
11.2 Cachexia Treatment Market Restraints
11.3 Cachexia Treatment Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Cachexia Treatment Industry Chain
12.2 Cachexia Treatment Upstream Analysis
12.3 Cachexia Treatment Midstream Analysis
12.4 Cachexia Treatment Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Cachexia Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Cachexia Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Cachexia Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Cachexia Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Alder Biopharmaceuticals Inc. Company Information, Head Office, and Major Competitors
Table 6. Alder Biopharmaceuticals Inc. Major Business
Table 7. Alder Biopharmaceuticals Inc. Cachexia Treatment Product and Solutions
Table 8. Alder Biopharmaceuticals Inc. Cachexia Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Alder Biopharmaceuticals Inc. Recent Developments and Future Plans
Table 10. GTx Inc. Company Information, Head Office, and Major Competitors
Table 11. GTx Inc. Major Business
Table 12. GTx Inc. Cachexia Treatment Product and Solutions
Table 13. GTx Inc. Cachexia Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. GTx Inc. Recent Developments and Future Plans
Table 15. Helsinn Group Company Information, Head Office, and Major Competitors
Table 16. Helsinn Group Major Business
Table 17. Helsinn Group Cachexia Treatment Product and Solutions
Table 18. Helsinn Group Cachexia Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Helsinn Group Recent Developments and Future Plans
Table 20. Merck & Co. Inc. Company Information, Head Office, and Major Competitors
Table 21. Merck & Co. Inc. Major Business
Table 22. Merck & Co. Inc. Cachexia Treatment Product and Solutions
Table 23. Merck & Co. Inc. Cachexia Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Merck & Co. Inc. Recent Developments and Future Plans
Table 25. Bristol-Myers Squibb Company Company Information, Head Office, and Major Competitors
Table 26. Bristol-Myers Squibb Company Major Business
Table 27. Bristol-Myers Squibb Company Cachexia Treatment Product and Solutions
Table 28. Bristol-Myers Squibb Company Cachexia Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Bristol-Myers Squibb Company Recent Developments and Future Plans
Table 30. Helsinn Healthcare S.A. Company Information, Head Office, and Major Competitors
Table 31. Helsinn Healthcare S.A. Major Business
Table 32. Helsinn Healthcare S.A. Cachexia Treatment Product and Solutions
Table 33. Helsinn Healthcare S.A. Cachexia Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Helsinn Healthcare S.A. Recent Developments and Future Plans
Table 35. PsiOxus Company Information, Head Office, and Major Competitors
Table 36. PsiOxus Major Business
Table 37. PsiOxus Cachexia Treatment Product and Solutions
Table 38. PsiOxus Cachexia Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. PsiOxus Recent Developments and Future Plans
Table 40. Purdue Pharma L.P. Company Information, Head Office, and Major Competitors
Table 41. Purdue Pharma L.P. Major Business
Table 42. Purdue Pharma L.P. Cachexia Treatment Product and Solutions
Table 43. Purdue Pharma L.P. Cachexia Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Purdue Pharma L.P. Recent Developments and Future Plans
Table 45. Eterna Zentaris Inc. Company Information, Head Office, and Major Competitors
Table 46. Eterna Zentaris Inc. Major Business
Table 47. Eterna Zentaris Inc. Cachexia Treatment Product and Solutions
Table 48. Eterna Zentaris Inc. Cachexia Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Eterna Zentaris Inc. Recent Developments and Future Plans
Table 50. Aphios Corporation Company Information, Head Office, and Major Competitors
Table 51. Aphios Corporation Major Business
Table 52. Aphios Corporation Cachexia Treatment Product and Solutions
Table 53. Aphios Corporation Cachexia Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Aphios Corporation Recent Developments and Future Plans
Table 55. Neurim Company Information, Head Office, and Major Competitors
Table 56. Neurim Major Business
Table 57. Neurim Cachexia Treatment Product and Solutions
Table 58. Neurim Cachexia Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Neurim Recent Developments and Future Plans
Table 60. Novartis AG Company Information, Head Office, and Major Competitors
Table 61. Novartis AG Major Business
Table 62. Novartis AG Cachexia Treatment Product and Solutions
Table 63. Novartis AG Cachexia Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Novartis AG Recent Developments and Future Plans
Table 65. SkyePharma Company Information, Head Office, and Major Competitors
Table 66. SkyePharma Major Business
Table 67. SkyePharma Cachexia Treatment Product and Solutions
Table 68. SkyePharma Cachexia Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. SkyePharma Recent Developments and Future Plans
Table 70. Global Cachexia Treatment Revenue (USD Million) by Players (2018-2023)
Table 71. Global Cachexia Treatment Revenue Share by Players (2018-2023)
Table 72. Breakdown of Cachexia Treatment by Company Type (Tier 1, Tier 2, and Tier 3)
Table 73. Market Position of Players in Cachexia Treatment, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 74. Head Office of Key Cachexia Treatment Players
Table 75. Cachexia Treatment Market: Company Product Type Footprint
Table 76. Cachexia Treatment Market: Company Product Application Footprint
Table 77. Cachexia Treatment New Market Entrants and Barriers to Market Entry
Table 78. Cachexia Treatment Mergers, Acquisition, Agreements, and Collaborations
Table 79. Global Cachexia Treatment Consumption Value (USD Million) by Type (2018-2023)
Table 80. Global Cachexia Treatment Consumption Value Share by Type (2018-2023)
Table 81. Global Cachexia Treatment Consumption Value Forecast by Type (2024-2029)
Table 82. Global Cachexia Treatment Consumption Value by Application (2018-2023)
Table 83. Global Cachexia Treatment Consumption Value Forecast by Application (2024-2029)
Table 84. North America Cachexia Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 85. North America Cachexia Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 86. North America Cachexia Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 87. North America Cachexia Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 88. North America Cachexia Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 89. North America Cachexia Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 90. Europe Cachexia Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 91. Europe Cachexia Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 92. Europe Cachexia Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 93. Europe Cachexia Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 94. Europe Cachexia Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Cachexia Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Cachexia Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 97. Asia-Pacific Cachexia Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 98. Asia-Pacific Cachexia Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 99. Asia-Pacific Cachexia Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 100. Asia-Pacific Cachexia Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 101. Asia-Pacific Cachexia Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 102. South America Cachexia Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 103. South America Cachexia Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 104. South America Cachexia Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 105. South America Cachexia Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 106. South America Cachexia Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 107. South America Cachexia Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Middle East & Africa Cachexia Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 109. Middle East & Africa Cachexia Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 110. Middle East & Africa Cachexia Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 111. Middle East & Africa Cachexia Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 112. Middle East & Africa Cachexia Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 113. Middle East & Africa Cachexia Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 114. Cachexia Treatment Raw Material
Table 115. Key Suppliers of Cachexia Treatment Raw Materials
Table 1. Global Cachexia Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Cachexia Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Cachexia Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Cachexia Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Alder Biopharmaceuticals Inc. Company Information, Head Office, and Major Competitors
Table 6. Alder Biopharmaceuticals Inc. Major Business
Table 7. Alder Biopharmaceuticals Inc. Cachexia Treatment Product and Solutions
Table 8. Alder Biopharmaceuticals Inc. Cachexia Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Alder Biopharmaceuticals Inc. Recent Developments and Future Plans
Table 10. GTx Inc. Company Information, Head Office, and Major Competitors
Table 11. GTx Inc. Major Business
Table 12. GTx Inc. Cachexia Treatment Product and Solutions
Table 13. GTx Inc. Cachexia Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. GTx Inc. Recent Developments and Future Plans
Table 15. Helsinn Group Company Information, Head Office, and Major Competitors
Table 16. Helsinn Group Major Business
Table 17. Helsinn Group Cachexia Treatment Product and Solutions
Table 18. Helsinn Group Cachexia Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Helsinn Group Recent Developments and Future Plans
Table 20. Merck & Co. Inc. Company Information, Head Office, and Major Competitors
Table 21. Merck & Co. Inc. Major Business
Table 22. Merck & Co. Inc. Cachexia Treatment Product and Solutions
Table 23. Merck & Co. Inc. Cachexia Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Merck & Co. Inc. Recent Developments and Future Plans
Table 25. Bristol-Myers Squibb Company Company Information, Head Office, and Major Competitors
Table 26. Bristol-Myers Squibb Company Major Business
Table 27. Bristol-Myers Squibb Company Cachexia Treatment Product and Solutions
Table 28. Bristol-Myers Squibb Company Cachexia Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Bristol-Myers Squibb Company Recent Developments and Future Plans
Table 30. Helsinn Healthcare S.A. Company Information, Head Office, and Major Competitors
Table 31. Helsinn Healthcare S.A. Major Business
Table 32. Helsinn Healthcare S.A. Cachexia Treatment Product and Solutions
Table 33. Helsinn Healthcare S.A. Cachexia Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Helsinn Healthcare S.A. Recent Developments and Future Plans
Table 35. PsiOxus Company Information, Head Office, and Major Competitors
Table 36. PsiOxus Major Business
Table 37. PsiOxus Cachexia Treatment Product and Solutions
Table 38. PsiOxus Cachexia Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. PsiOxus Recent Developments and Future Plans
Table 40. Purdue Pharma L.P. Company Information, Head Office, and Major Competitors
Table 41. Purdue Pharma L.P. Major Business
Table 42. Purdue Pharma L.P. Cachexia Treatment Product and Solutions
Table 43. Purdue Pharma L.P. Cachexia Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Purdue Pharma L.P. Recent Developments and Future Plans
Table 45. Eterna Zentaris Inc. Company Information, Head Office, and Major Competitors
Table 46. Eterna Zentaris Inc. Major Business
Table 47. Eterna Zentaris Inc. Cachexia Treatment Product and Solutions
Table 48. Eterna Zentaris Inc. Cachexia Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Eterna Zentaris Inc. Recent Developments and Future Plans
Table 50. Aphios Corporation Company Information, Head Office, and Major Competitors
Table 51. Aphios Corporation Major Business
Table 52. Aphios Corporation Cachexia Treatment Product and Solutions
Table 53. Aphios Corporation Cachexia Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Aphios Corporation Recent Developments and Future Plans
Table 55. Neurim Company Information, Head Office, and Major Competitors
Table 56. Neurim Major Business
Table 57. Neurim Cachexia Treatment Product and Solutions
Table 58. Neurim Cachexia Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Neurim Recent Developments and Future Plans
Table 60. Novartis AG Company Information, Head Office, and Major Competitors
Table 61. Novartis AG Major Business
Table 62. Novartis AG Cachexia Treatment Product and Solutions
Table 63. Novartis AG Cachexia Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Novartis AG Recent Developments and Future Plans
Table 65. SkyePharma Company Information, Head Office, and Major Competitors
Table 66. SkyePharma Major Business
Table 67. SkyePharma Cachexia Treatment Product and Solutions
Table 68. SkyePharma Cachexia Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. SkyePharma Recent Developments and Future Plans
Table 70. Global Cachexia Treatment Revenue (USD Million) by Players (2018-2023)
Table 71. Global Cachexia Treatment Revenue Share by Players (2018-2023)
Table 72. Breakdown of Cachexia Treatment by Company Type (Tier 1, Tier 2, and Tier 3)
Table 73. Market Position of Players in Cachexia Treatment, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 74. Head Office of Key Cachexia Treatment Players
Table 75. Cachexia Treatment Market: Company Product Type Footprint
Table 76. Cachexia Treatment Market: Company Product Application Footprint
Table 77. Cachexia Treatment New Market Entrants and Barriers to Market Entry
Table 78. Cachexia Treatment Mergers, Acquisition, Agreements, and Collaborations
Table 79. Global Cachexia Treatment Consumption Value (USD Million) by Type (2018-2023)
Table 80. Global Cachexia Treatment Consumption Value Share by Type (2018-2023)
Table 81. Global Cachexia Treatment Consumption Value Forecast by Type (2024-2029)
Table 82. Global Cachexia Treatment Consumption Value by Application (2018-2023)
Table 83. Global Cachexia Treatment Consumption Value Forecast by Application (2024-2029)
Table 84. North America Cachexia Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 85. North America Cachexia Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 86. North America Cachexia Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 87. North America Cachexia Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 88. North America Cachexia Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 89. North America Cachexia Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 90. Europe Cachexia Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 91. Europe Cachexia Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 92. Europe Cachexia Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 93. Europe Cachexia Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 94. Europe Cachexia Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Cachexia Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Cachexia Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 97. Asia-Pacific Cachexia Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 98. Asia-Pacific Cachexia Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 99. Asia-Pacific Cachexia Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 100. Asia-Pacific Cachexia Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 101. Asia-Pacific Cachexia Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 102. South America Cachexia Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 103. South America Cachexia Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 104. South America Cachexia Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 105. South America Cachexia Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 106. South America Cachexia Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 107. South America Cachexia Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Middle East & Africa Cachexia Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 109. Middle East & Africa Cachexia Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 110. Middle East & Africa Cachexia Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 111. Middle East & Africa Cachexia Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 112. Middle East & Africa Cachexia Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 113. Middle East & Africa Cachexia Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 114. Cachexia Treatment Raw Material
Table 115. Key Suppliers of Cachexia Treatment Raw Materials
LIST OF FIGURES
Figure 1. Cachexia Treatment Picture
Figure 2. Global Cachexia Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Cachexia Treatment Consumption Value Market Share by Type in 2022
Figure 4. Weight Loss Stabilizers
Figure 5. Appetite Stimulants
Figure 6. Progestogens
Figure 7. Corticosteroids
Figure 8. Combination therapies
Figure 9. Others
Figure 10. Global Cachexia Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 11. Cachexia Treatment Consumption Value Market Share by Application in 2022
Figure 12. Hospital Pharmacies Picture
Figure 13. Retail Pharmacies Picture
Figure 14. Drug Stores Picture
Figure 15. Online Picture
Figure 16. Global Cachexia Treatment Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 17. Global Cachexia Treatment Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 18. Global Market Cachexia Treatment Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 19. Global Cachexia Treatment Consumption Value Market Share by Region (2018-2029)
Figure 20. Global Cachexia Treatment Consumption Value Market Share by Region in 2022
Figure 21. North America Cachexia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Cachexia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Cachexia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Cachexia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East and Africa Cachexia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Cachexia Treatment Revenue Share by Players in 2022
Figure 27. Cachexia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 28. Global Top 3 Players Cachexia Treatment Market Share in 2022
Figure 29. Global Top 6 Players Cachexia Treatment Market Share in 2022
Figure 30. Global Cachexia Treatment Consumption Value Share by Type (2018-2023)
Figure 31. Global Cachexia Treatment Market Share Forecast by Type (2024-2029)
Figure 32. Global Cachexia Treatment Consumption Value Share by Application (2018-2023)
Figure 33. Global Cachexia Treatment Market Share Forecast by Application (2024-2029)
Figure 34. North America Cachexia Treatment Consumption Value Market Share by Type (2018-2029)
Figure 35. North America Cachexia Treatment Consumption Value Market Share by Application (2018-2029)
Figure 36. North America Cachexia Treatment Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Cachexia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 38. Canada Cachexia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 39. Mexico Cachexia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 40. Europe Cachexia Treatment Consumption Value Market Share by Type (2018-2029)
Figure 41. Europe Cachexia Treatment Consumption Value Market Share by Application (2018-2029)
Figure 42. Europe Cachexia Treatment Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Cachexia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 44. France Cachexia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 45. United Kingdom Cachexia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 46. Russia Cachexia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 47. Italy Cachexia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Cachexia Treatment Consumption Value Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Cachexia Treatment Consumption Value Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Cachexia Treatment Consumption Value Market Share by Region (2018-2029)
Figure 51. China Cachexia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 52. Japan Cachexia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 53. South Korea Cachexia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 54. India Cachexia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 55. Southeast Asia Cachexia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 56. Australia Cachexia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 57. South America Cachexia Treatment Consumption Value Market Share by Type (2018-2029)
Figure 58. South America Cachexia Treatment Consumption Value Market Share by Application (2018-2029)
Figure 59. South America Cachexia Treatment Consumption Value Market Share by Country (2018-2029)
Figure 60. Brazil Cachexia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 61. Argentina Cachexia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 62. Middle East and Africa Cachexia Treatment Consumption Value Market Share by Type (2018-2029)
Figure 63. Middle East and Africa Cachexia Treatment Consumption Value Market Share by Application (2018-2029)
Figure 64. Middle East and Africa Cachexia Treatment Consumption Value Market Share by Country (2018-2029)
Figure 65. Turkey Cachexia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 66. Saudi Arabia Cachexia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 67. UAE Cachexia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 68. Cachexia Treatment Market Drivers
Figure 69. Cachexia Treatment Market Restraints
Figure 70. Cachexia Treatment Market Trends
Figure 71. Porters Five Forces Analysis
Figure 72. Manufacturing Cost Structure Analysis of Cachexia Treatment in 2022
Figure 73. Manufacturing Process Analysis of Cachexia Treatment
Figure 74. Cachexia Treatment Industrial Chain
Figure 75. Methodology
Figure 76. Research Process and Data Source
Figure 1. Cachexia Treatment Picture
Figure 2. Global Cachexia Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Cachexia Treatment Consumption Value Market Share by Type in 2022
Figure 4. Weight Loss Stabilizers
Figure 5. Appetite Stimulants
Figure 6. Progestogens
Figure 7. Corticosteroids
Figure 8. Combination therapies
Figure 9. Others
Figure 10. Global Cachexia Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 11. Cachexia Treatment Consumption Value Market Share by Application in 2022
Figure 12. Hospital Pharmacies Picture
Figure 13. Retail Pharmacies Picture
Figure 14. Drug Stores Picture
Figure 15. Online Picture
Figure 16. Global Cachexia Treatment Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 17. Global Cachexia Treatment Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 18. Global Market Cachexia Treatment Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 19. Global Cachexia Treatment Consumption Value Market Share by Region (2018-2029)
Figure 20. Global Cachexia Treatment Consumption Value Market Share by Region in 2022
Figure 21. North America Cachexia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Cachexia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Cachexia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Cachexia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East and Africa Cachexia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Cachexia Treatment Revenue Share by Players in 2022
Figure 27. Cachexia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 28. Global Top 3 Players Cachexia Treatment Market Share in 2022
Figure 29. Global Top 6 Players Cachexia Treatment Market Share in 2022
Figure 30. Global Cachexia Treatment Consumption Value Share by Type (2018-2023)
Figure 31. Global Cachexia Treatment Market Share Forecast by Type (2024-2029)
Figure 32. Global Cachexia Treatment Consumption Value Share by Application (2018-2023)
Figure 33. Global Cachexia Treatment Market Share Forecast by Application (2024-2029)
Figure 34. North America Cachexia Treatment Consumption Value Market Share by Type (2018-2029)
Figure 35. North America Cachexia Treatment Consumption Value Market Share by Application (2018-2029)
Figure 36. North America Cachexia Treatment Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Cachexia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 38. Canada Cachexia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 39. Mexico Cachexia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 40. Europe Cachexia Treatment Consumption Value Market Share by Type (2018-2029)
Figure 41. Europe Cachexia Treatment Consumption Value Market Share by Application (2018-2029)
Figure 42. Europe Cachexia Treatment Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Cachexia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 44. France Cachexia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 45. United Kingdom Cachexia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 46. Russia Cachexia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 47. Italy Cachexia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Cachexia Treatment Consumption Value Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Cachexia Treatment Consumption Value Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Cachexia Treatment Consumption Value Market Share by Region (2018-2029)
Figure 51. China Cachexia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 52. Japan Cachexia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 53. South Korea Cachexia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 54. India Cachexia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 55. Southeast Asia Cachexia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 56. Australia Cachexia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 57. South America Cachexia Treatment Consumption Value Market Share by Type (2018-2029)
Figure 58. South America Cachexia Treatment Consumption Value Market Share by Application (2018-2029)
Figure 59. South America Cachexia Treatment Consumption Value Market Share by Country (2018-2029)
Figure 60. Brazil Cachexia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 61. Argentina Cachexia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 62. Middle East and Africa Cachexia Treatment Consumption Value Market Share by Type (2018-2029)
Figure 63. Middle East and Africa Cachexia Treatment Consumption Value Market Share by Application (2018-2029)
Figure 64. Middle East and Africa Cachexia Treatment Consumption Value Market Share by Country (2018-2029)
Figure 65. Turkey Cachexia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 66. Saudi Arabia Cachexia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 67. UAE Cachexia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 68. Cachexia Treatment Market Drivers
Figure 69. Cachexia Treatment Market Restraints
Figure 70. Cachexia Treatment Market Trends
Figure 71. Porters Five Forces Analysis
Figure 72. Manufacturing Cost Structure Analysis of Cachexia Treatment in 2022
Figure 73. Manufacturing Process Analysis of Cachexia Treatment
Figure 74. Cachexia Treatment Industrial Chain
Figure 75. Methodology
Figure 76. Research Process and Data Source
